本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aldeyra Therapeutics Inc

2.25
0.0000
盘后2.23-0.0200-0.89%19:30 EDT
成交量:52.07万
成交额:118.88万
市值:1.35亿
市盈率:-2.32
高:2.33
开:2.25
低:2.21
收:2.25
数据加载中...
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

SEC问询函

Form CORRESP - Correspondence
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans